US Patent Issued to Corcept Therapeutics on Oct. 7 for "Treatments for amyotrophic lateral sclerosis using dazucorilant" (British, American Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,882, issued on Oct. 7, was assigned to Corcept Therapeutics Inc. (Redwood City, Calif.).

"Treatments for amyotrophic lateral sclerosis using dazucorilant" was invented by Grace Mann (Menlo Park, Calif.), Iulia Cristina Tudor (Menlo Park, Calif.), William Guyer (Menlo Park, Calif.), Hazel Hunt (West Sussex, Great Britain) and Joseph Custodio (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Applicant discloses methods and compositions for treating a patient suffering from amyotrophic lateral sclerosis (ALS) comprising administration of a heteroaryl ketone fused azadecalin compound. In embodiments, the heteroaryl ketone fused azadecali...